Yiting Meng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Tyrosine Kinase

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific antibody-based nanoparticles (BiAbs) for Acute Myeloid Leukemia. Cancer research communications (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)
Atham Ali, Alvin Phan, Vijaya P Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, John Andrew MacKay, Houda Alachkar
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia. Cancer research communications 4 (8) (2024)